ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 117 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $85 | -26.7% | 36,923 | -3.2% | 0.01% | -27.3% |
| Q1 2023 | $116 | -57.5% | 38,160 | -67.4% | 0.01% | -67.6% |
| Q4 2022 | $273 | -99.8% | 117,191 | +23.6% | 0.03% | +41.7% |
| Q3 2022 | $181,000 | +311.4% | 94,800 | +487.5% | 0.02% | +242.9% |
| Q2 2022 | $44,000 | -54.6% | 16,136 | -50.3% | 0.01% | -46.2% |
| Q1 2022 | $97,000 | -90.6% | 32,453 | -89.5% | 0.01% | -92.4% |
| Q1 2021 | $1,032,000 | +1009.7% | 309,839 | +1081.6% | 0.17% | +1040.0% |
| Q4 2020 | $93,000 | – | 26,221 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |